The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/14876
StudyName: Eligibility Breast Neoplasms NCT02258451
Date of export from the portal: 02.07.2020
Date of Upload / last change: 03.05.2016
License: Creative Commons BY 4.0

----

Description: 
Study of Radium-223 Dichloride Versus Placebo and Treatment With Exemestane / Everolimus in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02258451
